FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA granted a supplemental approval for Levocetirizine dihydrochloride by Teva Pharmaceuticals USA, Inc. (generic) under an ANDA supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Idiopathic Urticaria

Drugs mentioned

• Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)